SENSEX NIFTY
Feb 14, 2013, 01.03 PM IST | Source: Moneycontrol.com

Dr Reddy's Q3 revenue seen up 5% at Rs 2,913cr

Strong growth in US generic drug sales will continue to drive revenue growth for Dr Reddy's Laboratories. The pharma major will report its third quarter earnings on Thursday.

Set email alert for

ADS BY GOOGLE

video of the day

Gung-ho over pharma; see BPCL rise 30-40% more: Dimensions

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.